Decreased Serum Levels of Epidermal Growth Factor in Adult Subjects with High-Functioning Autism

Biological Psychiatry

Volumn 62, Issue 3, 2007, Pages 267-269

  Suzuki, Katsuaki ^a   Hashimoto, Kenji ^b   Iwata, Yasuhide ^a   Nakamura, Kazuhiko ^a   Tsujii, Masatsugu ^c   Tsuchiya, Kenji J ^a   Sekine, Yoshimoto ^a   Suda, Shiro ^a   Sugihara, Genichi ^a   Matsuzaki, Hideo ^a   Sugiyama, Toshiro ^d   Kawai, Masayoshi ^a   Minabe, Yoshio ^a   Takei, Nori ^a   Mori, Norio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CHUKYO UNIVERSITY   (Japan)

^d AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

Author keywords

Autism; developmental disorders; ELISA; epidermal growth factor; growth factors; human blood

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; ARTICLE; AUTISM; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; NEUROPSYCHIATRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; AUTISTIC DISORDER; CASE-CONTROL STUDIES; EPIDERMAL GROWTH FACTOR; HUMANS; MALE; MATCHED-PAIR ANALYSIS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX;

EID: 34447276119     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.08.001     Document Type: Article

References (23)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
2. Baron-Cohen S., and Belmonte M.K. Autism: A window onto the development of the social and the analytic brain. Annu Rev Neurosci 28 (2005) 109-126
3. Belmonte M.K., Allen G., Beckel-Mitchener A., Boulanger L.M., Carper R.A., and Webb S.J. Autism and abnormal development of brain connectivity. J Neurosci 24 (2004) 9228-9231
4. Cohly H.H., and Panja A. Immunological findings in autism. Int Rev Neurobiol 71 (2005) 317-341
5. Connolly A.M., Chez M., Streif E.M., Keeling R.M., Golumbek P.T., Kwon J.M., et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59 (2006) 354-363
6. Croonenberghs J., Bosmans E., Deboutte D., Kenis G., and Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 45 (2002) 1-6
7. Ferrer I., Alcantara S., Ballabriga J., Olive M., Blanco R., Rivera R., et al. Transforming growth factor-alpha (TGF-α) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain. Prog Neurobiol 49 (1996) 99-123
8. Futamura T., Toyooka K., Iritani S., Niizato K., Nakamura R., Tsuchiya K., et al. Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol Psychiatry 7 (2002) 673-682
9. Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ, Sekine Y, et al. (in press): Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry [Epub ahead of print].
10. Hashimoto K., Shimizu E., Komatsu N., Watanabe H., Shinoda N., Nakazato M., et al. No changes in serum epidermal growth factor levels in patients with schizophrenia. Psychiatry Res 135 (2005) 257-260
11. Jyonouchi H., Geng L., Ruby A., and Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: Their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51 (2005) 77-85
12. Jyonouchi H., Sun S., and Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 46 (2002) 76-84
13. Levitt P., Eagleson K.L., and Powell E.M. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 27 (2004) 400-406
14. Lord C., Rutter M., and Le Couteur A. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24 (1994) 659-685
15. Nelson K.B., Grether J.K., Croen L.A., Dambrosia J.M., Dickens B.F., Jelliffe L.L., et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 49 (2001) 597-606
16. Nelson P.G., Kuddo T., Song E.Y., Dambrosia J.M., Kohler S., Satyanarayana G., et al. Selected neurotrophins, neuropeptides, and cytokines: Developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int J Dev Neurosci 24 (2006) 73-80
17. Pan W., and Kastin A.J. Entry of EGF into brain is rapid and saturable. Peptides 20 (1999) 1091-1098
18. Polleux F., and Lauder J.M. Toward a developmental neurobiology of autism. Ment Retard Dev Disabil Res Rev 10 (2004) 303-317
19. Riikonen R., and Vanhala R. Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome. Dev Med Child Neurol 41 (1999) 148-152
20. Rubenstein J.L., and Merzenich M.M. Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2 (2003) 255-267
21. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005) 67-81
22. Volkmar F.R., and Pauls D. Autism. Lancet 362 (2003) 1133-1141
23. Xian C.J., and Zhou X.F. Roles of transforming growth factor-alpha and related molecules in the nervous system. Mol Neurobiol 20 (1999) 157-183